Published Date: 08 Mar 2023
COVID-19 tracheostomy procedures can help reduce the risk of infection during these procedures, but are these safety recommendations being followed?
Read Full NewsAs part of NeurologyLive®'s Year in Review 2025, we've compiled some of the top trending migraine trials.
At ECTRIMS 2025, the William S. and Lois Stiles Edgerly Professor of Neurology at Yale School of Medicine discussed evolving insights into the disease pathogenesis of multiple sclerosis.
As part of NeurologyLive®'s Year in Review, take a look at our top expert interviews on the latest advances and use of artificial intelligence in neurology care.
Fibromyalgia in 2025: Year in Review
Rheumatoid Arthritis in 2025: Year in Review
Asthma in 2025: Year in Review
C3 Glomerulopathy in 2025: Year in Review
1.
When it comes to obesity-related cancers, where you shop for food matters
2.
Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.
3.
Immunotherapy after surgery is good for patients with advanced cancer
4.
PSA Testing Is Not Enough for Another Candidate for Prostate Cancer Screening.
5.
Kidney cancer: Understanding what a renal cell carcinoma diagnosis means
1.
Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence
2.
Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk
3.
Unlocking the Potential of Ferrotonia: A New Way to Harness Magnetic Energy
4.
Precision Oncology Advances: Neoantigen Therapies, TCR Strategies & Radiotherapy Innovations
5.
Insights into Doxorubicin and Liposomal Doxorubicin in Extra-Abdominal Desmoid-Type Fibromatosis
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
2.
Oropharyngeal Cancer in Relation to HPV Status
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation